Alcon and staar surgical announce expiration of hart-scott-rodino waiting period for alcon's acquisition of staar

Geneva & lake forest, calif.--(business wire)--alcon (six/nyse: alc), the global leader in eye care dedicated to helping people see brilliantly, and staar surgical company (nasdaq: staa) (“staar”), the manufacturer of the implantable collamer® lens (icl), today announced that the waiting period under the hart-scott-rodino antitrust improvements act of 1976, as amended (hsr), in connection with alcon's acquisition of staar, expired at 11:59 p.m. et on september 29, 2025. as previously announced,.
ALC Ratings Summary
ALC Quant Ranking